Pereiti prie pagrindinio turinio

Adresas

Panerių g. 246
48454 Kaunas
Lietuva

Darbo laikas

  • Pi – Pe
    9 :00 – 17 00
  • Še  
    Nedirbame    
  • Se
    Nedirbame   
Dog DNA testing illustration

Progressive Retinal Atrophy (MERTK-PRA)

Kodas: H166

74,72 €

Mėginio duomenys

Vienas tyrimas – vienas mėginys. Gyvūno ir savininko duomenys neprivalomi.

Ieškokite pagal mūsų ar laboratorijos numerį. Nerastas numeris išsaugomas kaip ankstesnis / išorinis numeris. Naujo fizinio mėginio nereikia.
Įdėjimo į krepšelį mygtukas pasirodys po to, kai aukščiau pasirinksite reikšmę

Short description

Progressive Retinal Atrophy (PRA) is a large group of genetic diseases in which the retina gradually degenerates over time, causing a progressive loss of vision.

General information

Progressive Retinal Atrophy (PRA) is a large group of genetic diseases in which the retina gradually degenerates over time, causing a progressive loss of vision. The specific variant of the disease analysed in this test is known as MERTK-PRA and is found in the Swedish Vallhund. It is caused by an autosomal recessive mutation to the MER proto-oncogene, tyrosine kinase (MERTK) gene.

Specifications

Breeds

Swedish Vallhund

Gene

MERTK

Chromosome

17

Organ

Sensory organs

Specimen

Swab, Blood EDTA, Blood Heparin, Semen, Tissue

Mode of Inheritance

Autosomal Recessive

Also known as

PRA

Clinical features

The symptoms of this form of Progressive Retinal Atrophy (PRA) can be divided into stages, with rod cells being affected first. This leads to vision deficits in low-light conditions, also known as night blindness. Affected dogs show symptoms that progress at varying rates, and early signs can be detected during a veterinary eye exam as early as 2 months of age. One of the initial signs includes changes in the reflectivity and appearance of the tapetum, a structure located behind the retina. As the disease advances, further vision loss occurs, with an average age of onset reported between 4 and 6 years. However there are known cases with an onset ranging from 1 to 12 years of age.

References

Pubmed ID: 28813472

Year published: 2017

Omia ID: 1932

Omia variant ID:

Turnaround information

  • 15 working days